Kardigan, Inc.

Direct answer

Kardigan, Inc. is publicly traded on NASDAQ under the ticker KARD.

Kardigan is a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen.

Can you invest in Kardigan, Inc.?

Yes. Kardigan, Inc. trades publicly on NASDAQ as KARD.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Kardigan, Inc.

Detailed equity research is provided by MarketSnap.